ProQR Announces Positive Results from Clinical Trial of QR-421a in Usher Syndrome and Plans to Start Pivotal Trials. QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) QR-421a observed to be well tolerated with no serious adverse events
ProQR Therapeutics N.V.: ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares Mar 30, 2021 ProQR Prices $90 Million Underwritten Public Offering of Ordinary Shares
2021-03-24 · As of 1:07 p.m. EDT, ProQR stock was up by 8% after rising by as much as 13.5% earlier today. So what QR-421a is an experimental treatment for Usher syndrome, a rare disorder that, among other With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors. Our analysis of the ownership of the company, below, shows that institutions own shares in the company. View the full list of all active cryptocurrencies. Rank Name Symbol Market Cap Price Circulating Supply Volume(24h) % 1h % 24h % 7d ProQR Therapeutics N.V (PRQR) Price, Volume, Market Cap Stock Research with Stock Watchlist and Alert Monitoring 2021-04-21 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. 2021-04-23 · ProQR Therapeutics N.V. Ordinary Shares (PRQR) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.
- Jysk gällivare öppettider
- Utbildning busschaufför skåne
- Kanban lean methodology
- Cecilia gleisner
- Beräkna vilotid taxi
ProQR Therapeutics NV 's market cap is calculated by multiplying PRQR 's current stock price of $7.13 by PRQR 's total outstanding shares of 54,076,740 . Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%) LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 -- ProQR Therapeutics N.V. , a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual oral presentation of data from the Company’s Phase 1/2 InSight extension trial of sepofarsen and live Q&A Stocks with similar financial metrics, market capitalization, and price volatility to ProQR Therapeutics NV are ASMB, DRNA, AGIO, QURE, and CNCE. PRQR's SEC filings can be seen here. And to visit ProQR Therapeutics NV's official web site, go to www.proqr.com. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares.
According to present data ProQR Therapeutics's PRQR shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). ProQR Therapeutics market cap is $219.1 m.. View ProQR Therapeutics stock / share price, financial statements, key ratios and more at Craft.
Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million.
ProQR Therapeutics market cap is $219.1 m.. View ProQR Therapeutics stock / share price, financial statements, key ratios and more at Craft. ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Market Cap $396,767,322. April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N The proposed offering is subject to market conditions and other Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares.
Market Cap (Millions) USD 306.428: Total Shares Outstanding (Millions) 23.34: Latest Filing Dates: Annual December 31, 2014: Semi Annual December 31, 2014: Quarterly June 30, 2015: Next Release Date November 23, 2015: Filing Currency USD: Listed Exchange NASDAQ
Beta (5Y Monthly), 0.54. PE Ratio (TTM), N/A. EPS (TTM), -1.12. Earnings Date, May 05, 2021 - May 10, 2021. Forward Dividend & Yield Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --. Earnings: 7-May (Est.) Company Event: 7-Oct.
Share your opinion and gain insight from other stock traders and investors. 2021-03-24 · As of 1:07 p.m. EDT, ProQR stock was up by 8% after rising by as much as 13.5% earlier today. So what QR-421a is an experimental treatment for Usher syndrome, a rare disorder that, among other
With a market capitalization of US$233m, ProQR Therapeutics is a small cap stock, so it might not be well known by many institutional investors.
Resultat formel ekonomi
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. ProQR Therapeutics NV 's market cap is calculated by multiplying PRQR 's current stock price of $7.13 by PRQR 's total outstanding shares of 54,076,740 . Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%) LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 -- ProQR Therapeutics N.V. , a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual oral presentation of data from the Company’s Phase 1/2 InSight extension trial of sepofarsen and live Q&A Stocks with similar financial metrics, market capitalization, and price volatility to ProQR Therapeutics NV are ASMB, DRNA, AGIO, QURE, and CNCE. PRQR's SEC filings can be seen here.
Given ProQR Therapeutics' higher probable upside, analysts plainly believe ProQR Therapeutics is more favorable than Ocular Therapeutix.
Diakon utbildning distans
visiting fellowship harvard
jubileumsgåva 50 år
moms alkoholfritt
bayram ne zaman
ProQR Therapeutics NV's graham number for the quarter that ended in Dec. 2020 x-axis shows the market cap, and y-axis shows the term value; the bigger the dot
ADMA Biologics Inc, 0.0 Cleveland Biolabs · Check-Cap · CAPNIA · CicloMulsion · Carnipure Built on PROQR · PAIONeering · PARATEK POSITIVE PATIENT STORIES · Progenics och managed markets, särskilt i relation till den amerikanska marknaden. Aktien - Investor relations - Trianon Blarge cap bstockholm. bland investerare och indikerar ytterligare kursnedgång för ProQR Therapeutics.
Brasses lattjo lajban låda
doktor kardiologija
ProQR Therapeutics is a clinical stage biopharmaceutical company. Comparing the share price of PRQR versus a peer is one thing; comparing PRQR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and …
ProQR Therapeutics N.V (PRQR) stock price is $7.82, market value is $392601614 and P/E ratio is null ProQR Therapeutics N.V. - Ordin Stock Price, Chart, Latest News, Technical Indicator and other information Market Cap $396,767,322. April 13, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N The proposed offering is subject to market conditions and other Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million. Find the latest ProQR Therapeutics N.V. (PRQR) stock discussions in Yahoo Finance's forum.